Summary: I am Professor of Cancer Medicine and Associate Dean at the University of Leeds and a Consultant Physician at St James’s University Hospital specialising in medical oncology.
Location: Cancer Research Building
Peter Selby is a consultant physician at St Jamess University Hospital, the Leeds Cancer Centre and Professor of Cancer Medicine since 1988 and Associate Dean at the University of Leeds. He has worked in cancer research and cancer care since 1976. After completing a Natural Sciences degree at the University of Cambridge in 1971, he undertook undergraduate medical training at Kings College Hospital in London and then medical and oncological training posts in Kings College Hospital, University College Hospital and the Royal Marsden Hospital in London and in the Princess Margaret Hospital and Ontario Cancer Institute in Toronto. He was a house officer, clinical research fellow and specialist trainee at the Institute for Cancer Research and Royal Marsden in London and became a Consultant and Senior Lecturer there in 1984. Peter was Head of Oncology and Cancer Research in Leeds University (1988-2010), of the Leeds Cancer Centre in the NHS (1997-2003), Director of the Leeds Biomedical and Health Research Centre (2008-2012) which linked basic science with translational and clinical research in Leeds and was Director of the Leeds Institute of Molecular Medicine (2002-2005 and 2010-2013). He was Consultant Advisor to the Chief Medical Officer on Cancer Services (1993-2000); National Clinical Research Director for the Imperial Cancer Research Fund (1997-2001); Director of the National Cancer Research Network, UK Clinical Research Network and NIHR Clinical Research Network (2000-2010); Trustee of Cancer Research UK (2012-2016); President of the Association of Cancer Physicians (2007-2018) and President of the European Cancer Concord (2014-2017).
His clinical interests have covered a wide range of cancer treatments and tumour sites including leukaemia, lymphoma, myeloma, melanoma, sarcoma and, most recently, urological cancers and cancers of teenagers and young adults. With Cliff Bailey and Ian Lewis from paediatric oncology he set up the Teenage and Young Adult Service in Leeds and he continued to practice within the team as much as possible until 2017. The team, now led by Dan Stark and Sue Morgan, was UK Cancer Team of the Year in 2013. His research programmes have been broad but always focused on research with potential to benefit patients and included high dose chemotherapy with bone marrow/stem cell transplants, antiviral treatments, antiemetics, combination chemotherapies, biological therapies, biomarkers, psychosocial oncology and psychometrics, clinical trials and health service innovations.